Article Information
History
- November 18, 2020.
Article Versions
- Version 1 (September 2, 2020 - 08:57).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Manju Mamtani, MD1,*,
- Ambarish M. Athavale, MD2,*,
- Mohan Abraham, MD2,
- Jane Vernik, MD2,
- Amatur R Amarah, MD2,
- Juan P. Ruiz, MD2,
- Amit J. Joshi, MD2,
- Mathew Itteera, MD2,
- Sara D Zhukovski, BS3,
- Ravi Prakash Madaiah, MS4,
- Blaine C White, MD5,
- Peter Hart, MD2 and
- Hemant Kulkarni, MD1,†
- 1M&H Research, LLC, San Antonio, Texas, USA
- 2Division of Nephrology, Department of Medicine, Cook County Health, Chicago, Illinois, USA
- 3Rush Medical College, Chicago, Illinois, USA
- 4Cerner Corporation, Kansas City, Missouri, USA
- 5Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA
- ↵†Address for correspondence:
Hemant Kulkarni, MD, 12023 Waterway Rdg, M&H Research, LLC, San Antonio, Texas, 78249, USA, Email: hemant.kulkarni{at}mnhresearch.com
↵* Equal contribution as first author
Posted November 18, 2020.
ASSOCIATION OF HYPERGLYCEMIA WITH HOSPITAL MORTALITY IN NONDIABETIC COVID-19 PATIENTS: A COHORT STUDY
